Literature DB >> 34362903

Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.

Jianzhen Lin1,2, Xinxin Peng3, Kun Dong4, Junyu Long1, Xuejiao Guo3, Hongyue Li3, Yi Bai1, Xu Yang1, Dongxu Wang1, Xin Lu1, Yilei Mao1, Xinting Sang1, Xuwo Ji3, Haitao Zhao5, Han Liang6,7.   

Abstract

Gallbladder carcinoma is the most common cancer of the biliary tract with dismal survival largely due to delayed diagnosis. Biliary tract intraepithelial neoplasia (BilIN) is the common benign tumor that is suspected to be precancerous lesions. However, the genetic and evolutionary relationships between BilIN and carcinoma remain unclear. Here we perform whole-exome sequencing of coexisting low-grade BilIN (adenoma), high-grade BilIN, and carcinoma lesions, and normal tissues from the same patients. We identify aging as a major factor contributing to accumulated mutations and a critical role of CTNNB1 mutations in these tumors. We reveal two distinct carcinoma evolutionary paths: carcinoma can either diverge earlier and evolve more independently or form through the classic adenoma/dysplasia-carcinoma sequence model. Our analysis suggests that extensive loss-of-heterozygosity and mutation events in the initial stage tend to result in a cancerous niche, leading to the subsequent BilIN-independent path. These results reframes our understanding of tumor transformation and the evolutionary trajectory of carcinogenesis in the gallbladder, laying a foundation for the early diagnosis and effective treatment of gallbladder cancer.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34362903     DOI: 10.1038/s41467-021-25012-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  47 in total

1.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

2.  Genetic alterations in gallbladder adenoma, dysplasia and carcinoma.

Authors:  Y T Kim; J Kim; Y H Jang; W J Lee; J K Ryu; Y K Park; S W Kim; W H Kim; Y B Yoon; C Y Kim
Journal:  Cancer Lett       Date:  2001-08-10       Impact factor: 8.679

Review 3.  Diagnosis of gallbladder tumors.

Authors:  Kazuo Inui; Junji Yoshino; Hironao Miyoshi
Journal:  Intern Med       Date:  2011-06-01       Impact factor: 1.271

Review 4.  Incidental carcinoma of the gallbladder.

Authors:  S Varshney; G Butturini; G Buttirini; R Gupta
Journal:  Eur J Surg Oncol       Date:  2002-02       Impact factor: 4.424

5.  The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway.

Authors:  Zhiqiang Feng; Jinglong Chen; Honglian Wei; Ping Gao; Jingsen Shi; Jinqian Zhang; Fenglin Zhao
Journal:  Exp Mol Pathol       Date:  2011-07-12       Impact factor: 3.362

Review 6.  Gallbladder cancer: lessons from a rare tumour.

Authors:  Ignacio I Wistuba; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

7.  Relation of adenoma to carcinoma in the gallbladder.

Authors:  S Kozuka; N Tsubone; A Yasui; K Hachisuka
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

8.  Neoplastic polyps in gallbladder: a retrospective study to determine risk factors and treatment strategy for gallbladder polyps.

Authors:  Yongliang Sun; Zhiying Yang; Xu Lan; Haidong Tan
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

Review 9.  Gallbladder cancer: epidemiology and outcome.

Authors:  Rajveer Hundal; Eldon A Shaffer
Journal:  Clin Epidemiol       Date:  2014-03-07       Impact factor: 4.790

10.  Gallbladder polyps - a follow-up study after 11 years.

Authors:  Linda Heitz; Wolfgang Kratzer; Tilmann Gräter; Julian Schmidberger
Journal:  BMC Gastroenterol       Date:  2019-03-18       Impact factor: 3.067

View more
  2 in total

Review 1.  Precursor Lesions of Gallbladder Carcinoma: Disease Concept, Pathology, and Genetics.

Authors:  Yuki Fukumura; Lu Rong; Yifare Maimaitiaili; Toshio Fujisawa; Hiroyuki Isayama; Jun Nakahodo; Masataka Kikuyama; Takashi Yao
Journal:  Diagnostics (Basel)       Date:  2022-01-28

Review 2.  Treatment of Resectable Gallbladder Cancer.

Authors:  Eduardo A Vega; Sebastian Mellado; Omid Salehi; Richard Freeman; Claudius Conrad
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.